LIQUIDIA CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.4 USD | -3.43% |
|
-6.55% | +2.30% |
| Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
| Apr. 01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 981M | - | - | ||||
| 700B | ||||||
| 358B | ||||||
| 330B | ||||||
| 287B | ||||||
| 236B |
